Εμβόλια Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women 31/12/2024 time to read 2 min read
Εμβόλια Evaluation of the attributable fraction and burden of HPV-related oropharyngeal cancers in Greece-the ORPHEAS study 09/10/2024 time to read 2 min read
Εμβόλια Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023) 18/06/2024 time to read 2 min read
Εμβόλια Rotavirus Genotypes in the Postvaccine Era: A Systematic Review and Meta-analysis of Global, Regional, and Temporal Trends by Rotavirus Vaccine Introduction 15/05/2024 time to read 2 min read
Εμβόλια A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study 21/01/2024 time to read 2 min read
Εμβόλια Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies Authors: Timothy J Chapman et al. 01/11/2023 time to read 2 min read
Εμβόλια A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines 26/10/2023 time to read 2 min read
Εμβόλια Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer Authors: Miriam Reuschenbach et al. 06/10/2023 time to read 2 min read
Εμβόλια A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1) Authors: Federico Martinon-Torres et al. 16/05/2023 time to read 2 min read
Εμβόλια A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED) Authors: Robert Lupinacci et al. 27/01/2023 time to read 2 min read
Εμβόλια A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION) Authors: Androniki Bili et al. 16/01/2023 time to read 2 min read